Source: European Medicines Agency (EU)
Visanne 2 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablets. White to off-white, round, flat-faced, bevelled-edge tablets with a debossed “B” on one side and a diameter of 7 mm. |
Each tablet contains 2 mg dienogest.
Excipient with known effect: each tablet contains 62.8 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dienogest |
Dienogest is a nortestosterone derivative with no androgenic but rather an antiandrogenic activity of approximately one third of that of cyproterone acetate. Dienogest binds to the progesterone receptor of the human uterus with only 10% of the relative affinity of progesterone. |
| List of Excipients |
|---|
|
Crospovidone |
The tablets are contained in blister packs consisting of green transparent films made of polyvinylidene chloride (PVDC) coated polyvinyl chloride (PVC) and metallic foils made of aluminum (mat side hot sealable).
Pack sizes: 28, 84 and 168 tablets.
Not all pack sizes may be marketed.
| Drug | Countries | |
|---|---|---|
| VISANNE | Austria, Canada, Ecuador, Finland, France, Hong Kong, Croatia, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
